Get Adobe Flash player

THE CELL THERAPY IN MEDICAL REHABILITATION (LITERATURE REVIEW AND OWN RESEARCH DATA)

Аuthors: V. O. Malakhov, V. S. Lychko

Pages: 352–360

Abstract

         

Current data concerning the latest developments in the field of cell technology were collected and analyzed et the paper. Prospects of this technology in regenerative medicine were described. Especially promising are techniques guided tissue regeneration and therapeutic angiogenesis, the essence of which lies in the activation of compensatory resources of damaged cells, tissues, circulatory system, stimulating mechanisms of recovery and regeneration, the replacement of lost structures and functions of the organism, organ or tissue.

Acute hypoxia and release a large number of mediators in the area of ischemia is a potent stimulator of angiogenesis. In the course of its own studies have shown that one of the mechanisms of activation of endogenous angiogenesis in the brain of a number of biologically active substances, which are contained in the composition of immunobiological preparation Cryocell-Cryocord. Additional its introduction into the treatment regimen results in significantly more active stimulation of angiogenesis in contrast to the group of animals treated with the standard treatment.

On the model of experimental focal cerebral ischemia in the dynamics of treatment with the addition of immunobiological preparation Cryocell-Cryokord it found that the drug exhibits a pronounced angioprotective properties, prevents capillary stasis, preserves the blood-brain barrier structure, activates the process of angiogenesis in necrotic area by increasing the number of functioning capillaries, and the exchange surface of the capillary bed.

The expressiveness of the vascular response to the 7th day of the experiment, a dense arrangement of the capillaries and the presence of multiple anastomoses indicate activation of collateral circulation in the necrotic area further treated Cryocell-Cryokord.

Keywords: angiogenesis, mesenchymal stem cells, cell therapy, rehabilitation.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Cymbalyuk VI, Lisyany VM. [The effect of different kinds neurotransplantation the course cerebellar injury in rats]. J. Nat. Academy Med. Sciences Ukraine. 2013; 19 (2): 171–183.
  2. Klunnik MO, Sych NS, Matiyashuk IG. [The using of stem cells of fetal origin in the treatment of patients with chronic heart failure and assess their impact on the morphological and functional parameters of left ventricular]. Cell Organ Transplant. 2014; 2 (1): 14–19.
  3. Lychko VS, Malakhov VO, Potapov OO. Morphological changes of the brain tissue in rats with experimental model of ischemic stroke in the dynamics of treatment by immunobiological preparation Cryocell-Cryocord. Modern Technologies in Medicine. 2015; 7 (4): 58–63.
  4. Bianco P. Mesenchymal stem cells. Ann. Rev. Cell Dev. Biol. 2014; Vol. 30: 677–704.
  5. Poon Z, Lee WC, Guan G. Bone Marrow regeneration promoted by biophysically sorted osteoprogenitors from mesenchymal stromal cells. Stem. Cells Transl. Med. 2015; Vol. 4: 56–65.
  6. Horwitz E, Le Blanc K, Dominici M. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005; Vol. 7: 393–395.
  7. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly selfrenewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA. 2001; Vol. 98: 7841–7845.
  8. Siddappa R, Licht R, Blitterswijk C. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J. Orthop. Res. 2007; Vol. 25: 1029–1041.
  9. Smith JR, Pochampally R, Perry A. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. STEM CELLS. 2004; Vol. 22: 823–831.
  10. Larson BL, Ylostalo J, Prockop DJ. Human multipotent stromal cells undergo sharp transition from division to development in culture. STEM CELLS. 2008; Vol. 26: 193–201.
  11. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 2012; Vol. 12: 383–396.
  12. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J. Cell. Biochem. 2009; Vol. 106: 984–991.
  13. Mabuchi Y, Morikawa S, Harada S. LNGFR1THY-11VCAM-1hi1cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Rep. 2013; Vol. 1: 152–165.
  14. Undale AH, Westendorf JJ, Yaszemski MJ. Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clinic. Proc. 2009; Vol. 84: 893–902.
  15. Mets T, Verdonk G. In vitro aging of human bone marrow derived stromal cells. Mech. Ageing. Dev. 1981; Vol. 16: 81–89.
  16. Tremain N, Korkko J, Ibberson D. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. STEM CELLS. 2001; Vol. 19: 408–418.
  17. Lee WC, Shi H, Poon Z. Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency. Proc. Natl. Acad. Sci. USA. 2014; Vol. 111: 4409– 4418.
  18. Oguro H, Ding L, Morrison SJ. SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors. Cell Stem Cell. 2013; Vol. 13: 102–116.
  19. Higuchi A, Ling Q-D, Chang Y. Physical cues of biomaterials guide stem cell differentiation fate. Chem. Rev. 2013; Vol. 113: 3297–3328.
  20. Digirolamo CM, Stokes D, Colter D. Propagation and senescence of human marrow stromal cells in culture: A simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 1999; Vol. 107: 275–281.
  21. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008; Vol. 8: 726–736.
  22. Whitfield MJ, Lee WC, Van Vliet KJ. Onset of heterogeneity in culture-expanded bone marrow stromal cells. Stem Cell Res. 2013; Vol. 11: 1365–1377.
  23. Ylostalo J, Bazhanov N, Prockop DJ. Reversible commitment to differentiation by human multipotent stromal cells in singlecell-derived colonies. Exp. Hematol. 2008; Vol. 36: 1390–1402.

CONTENT AND BALANCE OF TRACE ELEMENTS IN PLACENTA IN PHYSIOLOGICAL PREGNANCY

Аuthors: I. I. Shkolna, V. E. Markevich, H. F. Tkach, O. V. Hordiienko

Pages: 361–366

Abstract

         

Placenta has a number of features that ensure the passage of many biological substances to the fetus as well as the function of barrier for certain substances. According to researchers, it can be used as a marker of unfavorable environmental action.
The aim of study: To identify regulatory indicators of content of essential trace elements (Fe, Cu, Co, Zn, Mg, Mn) in placenta of women which born healthy full term neonates. We also obtained ratios between the essential trace elements that can be used as a normative. We investi-gated the correlation between these microelements in placenta during physiological pregnancy on 37–41 week of gestation.
We have studied the contents of essential trace elements (Fe, Cu, Co, Zn, Mg, Mn) in placenta of women with physiological course of pregnancy.
For the determination of trace elements in placenta used atomic absorption spectrophotometer C-115 M1, equipped with a computer console to automatically calculate the microelements content producing by JSC «Selmi» (Ukraine).
We investigated the concentrations of trace elements in placenta (Fe = 79,91 ± 8,94 mg/g, Cu = 0,83 ± 0,04 mg/g, Co = 0,55 ± 0,2 mg/g, Zn = 45 ± 6,89 mg/g, Mg = 12,22 ± 0,92 mg/g, Mn = 0,73 ± 0,05 mg/g) and proposed the ratio of essential trace elements for using in practice (Fe/Cu=98,84 ± 12,84, Fe/Co = 6185,11 ± 3709,65, Fe/Zn = 2,11 ± 0,38, Fe/Mg = 7,12 ± 1,04, Fe/Mn = 113,25 ± 13,97, Cu/Co = 51,28 ± 27,83, Cu/Zn = 0,024 ± 0,004, Cu/Mg = 0,07 ± 0,007, Cu/Mn = 1,18 ± 0,09, Co/Zn = 0,02 ± 0,01, Co/Mg = 0,04 ± 0,016, Co/Mn = 0,68 ± 0,25, Zn/Mg = 4,11 ± 0,797, Zn/Mn = 64,46 ± 10,51, Mg/Mn = 17,3 ± 1,72). It was noted that a moderate positive correlation between the content of copper and zinc in placenta existed.
Positive correlation of medium strength of content of copper and zinc in placenta was observed. We investigated indicators of content and balance of essential trace elements in placenta of women which born healthy full term neonates. These results should be used as normative
.

Keywords: trace elements, placenta, fetus.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Gude NM, Roberts CT, Kalionis B, King RG. [Growth and function of the normal human placenta]. Thromb. Res. 2004; 114(5–6):397–407.
  2. Desforges M, Sibley CP. [Placental nutrient supply and fetal growth]. Int. J. Dev. Biol. 2010; 54(2–3):377–390.
  3. Iyengar GV, Rapp A. [Human placenta as a ‘dual’ biomarker for monitoring fetal and maternal environment with special reference to potentially toxic trace elements. Part 3. Toxic trace elements in placenta and placenta as a biomarker for these elements]. Science of The Total Environment. 2001; 280: 221–238.
  4. Osman K, Akesson A, Berglund M, Bremme K, Schutz A, Ask K, Vahter M. [Toxic and essential elements in placentas of Swedish women]. Clin. Biochem. 2000; 33(2):131–138.
  5. Stawarz R, Formcki G, Chrobaczynska M, Czajkowska M, Chryc K, Kuczkowska-Kuzniar A, Massanyi P, Skalba P. [Accumulation of cadmium and lead in placenta and amnion of women from upper Silesian region, Poland]. Environ. Res. Dev. 2011; 5(4):871–879.
  6. Amaya E, Gil F, Freire C, Olmedo P, Fernandez-Rodrıguez M, Fernandez MF, Olea N. [Placental concentrations of heavy metals in a motherchild cohort]. Environ. Res. 2013;120:63–70.
  7. Zadrożna M, Nowak B, Żołnierek M, Zamorska L, Niweliński J. Human Placenta as a Biomarker of Environmental Toxins Exposure – Long-Term Morphochemical Monitoring, Recent Advances in Research on the Human Placenta. InTech, 2012. pp.19–52. doi: 10.5772/32918
  8. Esteban M, Castaño A. [Noninvasive matrices in human biomonitoring: A review]. Environ. Int. 2009; 35(2):438–449.
  9. Smolders R, Schramm KW, Nickmilder M, Schoeters G. [Applicability of non-invasively collected matrices for human biomonitoring]. Environmental Health. 2009;8:8–18.
  10. Collard KJ. [Iron homeostasis in the neonate]. Pediatrics. 2009;123:1208–1216.
  11. Balesaria S, Hanif R, Salama MF, Raja K, Bayele HK, McArdle H, Srai SK. [Fetal iron levels are regulated by maternal and fetal Hfe genotype and dietary iron]. Haematologica. 2012;97(5):661–670.
  12. Izquierdo Alvarez S, Castanon SG, Ruata ML, Aragues EF, Terraz PB, Irazabal YG, Gonzalez EG, Rodriguez BG. [Updating of normal levels of copper, zinc and selenium in serum of pregnant women]. Journal of Trace Elements in Medicine and Biology. 2007; 21 Suppl 1:49–52.
  13. Zeyrek DSoran MCakmak AKocyigit AIscan A. [Serum copper and zinc levels in mothers and cord blood of their newborn infants with neural tube defects: a case-control study]. Indian Pediatr. 2009;46(8):675–680.
  14. Gambling L, Dunford S, Wallace DI, Zuur G, Solanky N, Srai SK, McArdle HJ. [Iron deficiency during pregnancy affects postnatal blood pressure in the rat]. J Physiol. 2003;552(Pt 2):603–610.
  15. Marquardt MLDone SLSandrock MBerdon WEFeldman KW. [Copper deficiency presenting as metabolic bone disease in extremely low birth weight shot–gut infants]. Pediatrics. 2012;130(3):e695–698.
  16. Legostaeva GA, Zaksas NP, Gluhcheva YG, Sedykh SE, Madzharova ME, Atanassova NN, Buneva VN, Nevinsky GA. [Effect of CoCl2 on the content of different metals and a relative activity of DNA-hydrolyzing abzymes in the blood plasma of mice]. J. Mol. Recognit. 2013;26:10–22.
  17. Vasudevan H, McNeill JH. [Chronic cobalt treatment decreases hyperglycemia in streptozin-diabetic rats]. 2007;20(2):129–134. 
  18. Islam MN, Chowdhury AK, Siddika M, Hossain MA, Hossain MK. [Effect of zinc on growth of preterm babies]. Mymensingh Med J. 2009;18(1):125–130.
  19. Khadem N, Mohammadzadeh A, Farhat ASValaee LKhajedaluee MParizadeh SM. [Relationship between low birth weight neonate and maternal serum zinc concentration]. Iran Red Crescent Med J. 2012;14(4):240–244.
  20. Wulf K, Wilhelm A, Spielmann M, Wirth S, Jenke AC. [Frequency of Symptomatic Zinc Deficiency in very Low Birth Weight Infants]. Klin Padiatr. 2013;225(1):13–17.
  21. Upadhyaya C, Mishra S, Ajmera P, Sharma P. [Serum iron, and zinc status in Maternal and cord blood]. Indian J Clin Biochem. 2004;19(2): 48–52.
  22. Ohata YOzono KMichigami T. [Current concepts in perinatal mineral metabolism]. Clin Pediatr Endocrinol. 2016;25(1):9–17.
  23. Aschner M, Guilarte TR, Schneider JSZheng W. [Manganese: recent advances in understanding its transport and neurotoxicity]. Toxicol Appl Pharmacol. 2007;221(2):131–147.
  24. Erikson KM, Thompson K, Aschner J, Aschner M. [Manganese neurotoxicity: a focus on the neonate]. Pharmacol Ther. 2007;113(2):369–377.
  25. Yoon M, Schroeter JD, Nong A, Taylor MD, Dorman DC, Andersen ME, Clewell HJ 3rd. [Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development]. Toxicol Sci. 2011;122(2):297–316.
  26. Tholin K, Sandström B, Palm R, Hallmans G. [Changes in blood manganese levels during pregnancy in iron supplemented and non supplemented women]. J Trace Elem Med Biol. 1995;9(1):13–17.
  27. Zaitsev IV, Zaitseva OE. [Uroven' soderzhaniya tyazhelykh metallov v platsente zhenshchin i pupovine novorozhdennykh astrakhanskoy oblasti]. Vestnik of astrakhan state technical university. 2004;2(21):172–17.
  28. Markevich VE, Turova LO, Tarasova IV, Markevich VV. [Znachennya defіtsitu ta disbalansu mіkroelementіv u sistemі mati-platsenta-plіd u razі zatrimki vnutrіshn'outrobnogo rozvitku ploda]. Pedіatrіya, Akusherstvo ta Gіnekologіya. 2009;6:12–15.
  29. Mbofung CMF, Subbarau VV. [Trace elements (Zinc, copper, iron and magnesium) concentrations in human placenta and their relationship to birth weight of babies]. Nutrition Research. 1990;10(4):359–366.
  30. Sakamoto M, Yasutake A, Domingo JL, Chan HM, Kubota M, Murata K. [Relationships between trace element concentrations in chorionic tissue of placenta and umbilical cord tissue: Potential use as indicators for prenatal exposure]. Environment International. 2013;60:106–111.
  31. Radomanski T, Sikorski R. [Human placenta magnesium and the contamination with cadmium and lead of placenta]. J Perinat Med.1992;20:181.

I. I. Shkolna,

V. E. Markevich,

H. F. Tkach,

O. V. Hordiienko

NEUROLOGICAL DISORDER STRUCTURE FOR THE WORKERS OF MACHINE-BUILDING ENTERPRISE. WAYS OF PROPHYLAXIS AND DECREASE OF MORBIDITY

Аuthors: O. S. Chynyak, O. I. Kolenko, M. I. Dyachenko

Pages: 367–373

Abstract

         

Introduction. In the recent years, the increased number of nervous system diseases has been noted in Ukraine, especially among working-age population. Nervous system diseases ranked fourth among occupational diseases. The ways to prevent and reduce the incidence are early diagnosis and timely preventive maintenance that will keep highly qualified, experienced professionals. An important role for periodic medical examinations aimed at: early detection and early signs of general industrial-caused diseases, dynamic monitoring of workers' health in terms of harmful and dangerous factors of production and the labor process.

Purpose. The main purposes of the research are to identify and to analyze the factors that affect workers at machine-building enterprise, and research of modern methods of prevention and measures to reduce occupational diseases.

Materials and Methods. The research was conducted at the 4th regional clinical hospital department of preventive examinations. There were about 12 000 employees at Public Joint Stock Company “Sumy NPO” in 2014. 6866 workers worked in hazardous conditions that represented 57.21 % of the total number of employees. It was determined that the most common factors that affect engineering company’s employee are: vibration, great physical overload, forced posture fixed, constant load on different parts of the spine, and adverse microclimatic, traumatic factors. To clarify the features of the health status and changes in the nervous system of workers under the influence of a complex environment factors in-depth survey of 250 employees was carried out: 100 boilermakers (group 1), 70 blacksmiths (group 2) and 80 crane operators (group 3). Age of the patients-boilermakers ranged from 22 to 62 years, averaging – (45.3 ± 0.8) years.

Discussion. According to the results of periodic medical examinations of workers employed in a harmful and hazardous working environment in 2014, the structure of neurological diseases in the first group (boilermaker) was: angioneurosis upper extremities – 20 %, osteochondrosis of the lumbosacral spine – 12 %, diseases caused by circulatory disturbance of the brain – 7 %, of those 2 % – the consequences of brain stroke, 1 % – post-traumatic neuropathy median and radial nerves. In the second group (blacksmiths): degenerative lesions of the lumbosacral spine – 14.29 %, angioneurosis upper extremities – 8.6 %, degenerative lesions of the cervical spine – 4.3 %. In the third group (crane operators): osteochondrosis of the cervical spine – 18.7 %, diseases caused by circulatory disturbance of the brain – 7.5 %, osteochondrosis of the lumbosacral spine – 6.3 %. In the structure of neurological diseases in engineering industry workers, a dominant position among CNS diseases occupy: degenerative lesions of spine, chronic brain ischemia, angioneurosis upper extremities. Prevention must include improved system of measures aimed at preserving and improving the health of employees. Measures should include comprehensive, organizational, technical, medical, and rational use of work and rest as well as individual and collective organization of nutrition.

Keywords: occupational diseases, hand-arm vibration, machine-building environment, crane operators, boilermakers, blacksmith.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Grechkivska NV. [State of occupational morbidity of individuals working in harmful and dangerous conditions at enterprises of Kyiv]. Ukr. J.of Occup. Health Probl. 2012; 3(31): 14–20.
  2. Nikitin AS. [Sanitary – hygienic characteristic of working conditions and the state of health of workers of the enterprise of mechanical engineering] Ros. Med. Biol. Vestn. 2010; 4. Retrived from: http://www.vestnik.rzgmu.ru/data/files/2012/12/Никитин.pdf
  3. Kolomoets MYu, Khukhlina OS, Professiyni khvoroby. [Occupational diseases]. Kyiv: Zdorov’ya, 2004. 628.
  4. Timoshina DP, Lubjanova IP. [Occupational selection as a social powerful component of medical surveys of working population]. Actual problems of transport medicine. 2008; 3 (13): 65–72.
  5. Tkachyshyn VS. [Disease of locomotorium and interfacing frames caused by a physical overload during industrial activity. lecture 5. a professional dyskinesia, disease of muscles and peripheric nerves]. Ukr. Reum. J. 2006; 23 (1):11–17.
  6. Hornyk VM. Professyni zahvoruvannia nervovoy systemy. [Occupational diseases of nervous system]. Kyiv: 1986. 40 p.
  7. Kundiev YuI, Nagorna AM, Chernyuk VI. [Occupational health in Ukraine and ways to improve it]. J. AMNU. 2007; 13(3):464–475.
  8. Kundiev YuI, Nahorna AM, Dobrovolsky LO. [Comparative characteristics of the state of occupational morbidity in Ukraine and in the world]. Ukr. J.of Occup. Health Probl. 2009; 2(18): 3–11.
  9. Kundiev YuI, Nahorna AM. Professiyne zdorov’ya. Epidemiologichny analis professiynogo zdorov’ya v Ukraini [Professional health in Ukraine. Epidemiological analysis of occupational health in Ukraine]. Kyiv: Avizenna, 2006. 316.
  10. Tkachyshyn VS. [Occupational diseases of locomotorium and interfacing frames caused by influence of series of harmful production factors. Lecture 6. Physical, chemical and biological factors during industrial activity]. Ukr. Reum. J. 2005; 24(2):11–17.

ETHIOLOGICAL STRUCTURE OF INFECTIOUS DISORDERS OF THE EAR, NOSE, AND THROAT

Аuthors: V. V. Minukhin, N. I. Kovalenko, T. M. Zamazii, I. V. Novikova, G. P. Taranenko

Pages: 374–381

Abstract

         

Actuality: There is a change of the general range of infectious agents and their sensitivity to antibiotics. Besides increasing role of opportunistic fungi most of all fungi of the genus Candida in the pathogenesis of infectious diseases of ENT organs is found, and increasing number of strains of the genus Candida fungi resistant to many antifungal preparations is noted.

Objective: studying of the species composition of microflora in ENT pathology and determination of its susceptibility to antimicrobial agents.

Materials and methods: Bacteriological research of various clinical materials from 347 patients with infectious diseases of ENT organs is conducted. Microbiological examination included an isolation of pathogens, identification by morphological, cultural and biochemical properties, determination of the sensitivity of microflora to antibiotics by a diffusion method in agar (the method of standard discs).

Results and discussion: The study found that the leading role in the etiology of infectious disorders of the ear, nose, throat belonged to streptococci of viridans group, S. aureus, S. epidermidis, S. anhemolyticus and fungi Candida species. The greatest sensitivity of all isolated strains was shown to cephoperazone and ciprofloxacin. Tigecycline, ceftriaxone, cephepime and meronem revealed high activity against all bacteria except E. faecalis. Proportion of Candida species was 22.9 %, and 85.8 % of the strains isolated from the nasopharynx, and 81.8 % of the strains isolated from the external ear have been presented in association with the bacteria. 82.5–98.4 % strains were resistant to azoles and amphotericin. Isolated strains of fungi have shown the greatest sensitivity to nystatin.

Conclusions: The obtained data confirmed the requirement to determine the most significant pathogenic flora, which causes diseases of the ENT organs and the respiratory tract organs, its sensitivity to antibiotics, monitoring of resistance at the level of the individual patient, as well as at the regional and country level.

Keywords: microflora of upper respiratory tract, sensitivity to antibiotics, upper respiratory tract infections.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Volosovets AP, Kryvopustov, SP, Yulish EI. [Modern views on the problem of antibiotic resistance and its overcoming in clinical pediatrics]. Gazeta «Novosti mediciny i farmacii», Antimikrobnaja i protivovirusnaja terapіja. 2008;236. Retrieved from: http://www.mif-ua.com/archive/article/4800.
  2. Yulish EI, Podolyaka VL, Bukhtiyarov EV, Koreneva LS. [Change of etiological structure of pathogens of community-acquired pneumonia and their sensitivity to antibiotics in children over five years (2001–2006)]. Zdorov'e rebenka. 2006;2. Retrieved from: http://www.mif-ua.com/archive/article/927.
  3. Booth G. Antibiotikorezistentnost'. [Antibiotic Resistance. Perspective on the problem and its solution]. Gazeta «Novosti mediciny i farmacii» Antimikrobnaja i protivovirusnaja terapija. 2008;263. Retrieved from: http://www.mif-ua.com/archive/article/6898.
  4. Kuzyk PV, Kurovets LM. [The Evolution of antibiotic resistance of staphylococci: a global threat and new strategic directions of chemotherapy]. Proceedings of The XIII Congress of society of microbiologists of Ukraine named after. SM. Vinogradsky. Yalta, 2013, p. 275.
  5. Shostakovich-Koretskaya LR. [The Problem of antimicrobial resistance in the treatment of acute respiratory infections in children]. Zhurnal «Zdorov'e rebenka». 2011;3(30). Retrieved from: http://www.mif-ua.com/archive/article/21925.
  6. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:2096.
  7. Canton R, Morosini MI. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol. Rev. 2011;35(5):977–991.
  8. Zabolotnyi DI, Wolska EG. [Modern diagnosis and treatment of fungal infections of the upper respiratory tract and ear]. Mistectvo lіkuvannja. 2004;4. Retrieved from: http://m-l.com.ua/?aid=163.
  9. Smiyanov VA, Ivakhnyuk TV. [The problem of candida-bacterial associations in diseases of ENT-organs]. Gazeta «Novosti mediciny i farmacii». 2007;17(224). Retrieved from: http://www.mif-ua.com/archive/article/3804.
  10. Bars’ky OB, Yaremchuk SE, Vol’s’ka OG. [Mycoses of the ENT-organs: etiology, diagnostics, medical treatment]. Medicina zalіznichnogo transportu Ukraїni. 2004;4:41–44.
  11. Sopkova JV, Kostenko IG, Pokas EV. [Candida. Properties and role in the etiology of human diseases (Part 4)]. Ukraїns'kij medichnij vіsnik. 2015;3(96). Retrieved from: http://therapia.ua/therapia/2015-/3-96/kandidy-svoistva-i-rol-v-etiologii-zabolevanii-cheloveka-chast-41.
  12. Zabolotnyy DI, Zaritskaya IS, Wolska, OG. [The Role of fungi in the pathology of the upper respiratory tract and ear]. Zhurn. vushnih, nosovih і gorlovih hvorob. 2002;5:2-15.
  13. Pukhlik SM, Titarenko OV. [Mycosis in otorhinolaryngology. The experience with the drug "Micofin"]. Zhurn. vushnih, nosovih і gorlovih hvorob. 2011;2:35-49.
  14. Sergeev AYu, Sergeev YuV. [Modern antimycotics and principles of antifungal therapy]. Gribkovye infekcii: rukovodstvo dlja vrachej. 2004;55–143.
  15. Goіbek K. Strzelczyk JK., Owczarek A. Selected mechanisms of molecular resistance of Candida albіcans to azole drugs. Acta Biochim. Pol. 2015;21:47–52.
  16. On Approval Guidelines "Determination of the Sensitivity of Microorganisms to Antibiotics." Ministry of Public Health of USSR Mandate dated 05.04.2007 № 167. 52p.
  17. On the Unification of microbiological (bacteriological) research methods used in clinical diagnostic laboratories of medical institutions: Ministry of Public Health of USSR Mandate dated 22.04.1985 № 535. 123p.

DIAGNOSTICS OF CONGENITAL AND ACQUIRED HEMORRHAGIC DISEASES IN PATIENTS WITH ISOLATED PROLONGED ACTIVATED PARTIAL THROMBOPLASTIN TIME USING LABORATORY ALGORITHM

Аuthors: V. V. Krasivska, O. V. Stasyshyn

Pages: 382–395

Abstract

         

The purpose of the study was to establish the causes of hemorrha­gic syndrome in patients and develop the laboratory diagnostics algorithm of coagulative haemostasis with the help of two groups of correctional tests, screenings and specification diagnosis tests.

Materials and Methods: The subject of the research constitutes 61 patients with hemorrhagic syndrome, who contacted us to be diagnosed. All the patients underwent coagulative screenings. The research includes patients with isolated prolonged activated partial thromboplastin time (APTT), which indicates a disorder of the internal mechanism of trombo­genesis system due to a deficiency or inhibition of coagulation factors. In order to identify disorders in the coagulation systems in all the patients, two groups of correctional tests were carried out, which were based on APTT - interchangeable test and screening test to identify the presence of inhibitors for coagulation factors. The purpose of the interchangeable tests was to determine the APTT after mixing the test plasma at a ratio of 1:1 with the control (normal) plasma, with the deficient factor FVIII and the deficient FIX plasma separately.

To differentiate the deficit factor with the pathological inhibitors of coagulation system, a screening test on inhibitors was carried out: the APTT mix was compared with normal plasma and test plasma at a ratio of 1:1, when the components were incubating separately (mix 1), and as a 1:1 mixture of the test and normal plasma at 37 ºС for 60 minutes (mix 2). To determine the inhibitor type we analyzed the availability of correction in mix 1 and mix 2 and assessed the accuracy of the difference in indicators within the group. All the patients underwent the diagnosis specification tests (FVIII, FIX, von Willebrand factor (vWF:Rco), quantity measurement of inhibitor titres and lupus anticoagulant presence).

Results and discussion: Among 61 patients with hemorrhagic syndrome and isolated prolonged APTT 34,4 % were diagnosed with hemophilia A, 11,5 % with hemophilia B, 13,1 % with hemophilia A with inhibitor of blood coagulation factor VIII, 6,5 % with acquired hemophilia A, 1,6 % with acquired hemophilia B, 4,9 % with von Willebrand disease and 27,9 % with anti-phospholipid syndrome (APS). The algorithm which includes combining two types of correctional tests, mixing tests and pathological coagulation inhibitor screening test was developed for laboratory diagnostics of coagulopathies. Firstly mixing tests are carried out in patients with hemorrhagic syndrome and isolated prolonged APTT. The correction of the clotting time after mixing the test plasma with the normal plasma indicates the deficit of clotting factors and absence of the immediate autoimmune type II inhibitor. After normalization of APTT with the deficient FVIII plasma one should proceed assay of FIX and after normalization with the deficient FIX plasma - with the assay of FVIII and vWF:Rco. In case of correction of all the interchangeable probes it’s vital to indicate the FXI activity because it is present in normal, deficient FVIII and deficient FXI plasma. Low level FVIII shows presence of hemophilia A, FVIII and/or vWF:Rco – presence of von Willebrand disease (I, III type), FIX – presence of hemophilia B, F XI – presence of hemophilia C. Little or no correction of prolonged APTT in all three interchangeable probes allows us to suspect with the high probability type II inhibitor (acquired against clotting factors or LA). In this case suspicion on resistance to a replacement therapy in patients with hemophilia A, B it is advisable to proceed with the second group of correctional tests-screening test on inhibitors. The difference between the two mixes is > 2 sec and the correction in mix 1 and mix 2 is absent shows the influence of the immediate type II inhibitor of the clotting system. Further differential diagnostics is based on LA identification, which can suppress phospholipid-dependent coagulation reactions. It’s a well-known fact that LA is hardly ever accompanied by bleedings, which allows to clinically differentiate LA from spontaneous inhibitors with immune coagulopathy, which is accompanied by life threatening bleedings. In case LA is negative it is advisable to proceed with the assay FVIII, FIX, FX. If the level of one of the factors is low it is necessary to identify the quantity of inhibitor antibodies. Inhibitor titre > 0.6 BU/ml indicates the presence of acquired immune coagulopathy.

Conclusions. The researched algorithm, which corresponds to the needs of a specialized coagulative laboratory, allows diagnosing the deficit of factors, the differentiation of the progressive type I alloimmune inhibitor with immediate autoimmune type II inhibitor and a decrease in the time of diagnosis specification.

Keywords: hemophilia, inhibitor, APTT, acquired immune coagulopathy, lupus anticoagulant, diagnostic algorithm.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Кrasivska V, Stasyshyn O. [Pathologic inhibitors of hemostasis: distribution, diagnostics, clinical manifestation and treatment]. Ukr. Med. J. 2012; 4(90), VII/VIII:162 –168.
  2. Кrasivska V, Stasyshyn O, Novak V. Laboratorna diagnostyka vrodgenyh gemoragichnyh zahvoruvan [Laboratory diagnosis of congenital haemorrhagic disease]. Lviv: RVA Triumf Publ., 2014. 71 p.
  3. Kitchen S, McCraw A. Diagnosis of haemophilia and other bleeding disorders: A laboratory manual. 1st. Montreal: WFH, 2000. 108 p.
  4. Kitchen S, McCraw A, Echenagucia M. Diagnosis of haemophilia and other bleeding disorders: A laboratory manual. 2nd. Montreal: WFH, 2010. 144 p.
  5. McCraw A, Hillarp A, Echenagucia M. Considerations in the laboratory assessment of haemostasis. Haemophilia. 2010;16(5):74–78. doi: 10.1111/j.1365-2516.2010.02302.x.
  6. Van Den Berg HM. Epidemiological aspects of inhibitor development redefinethe clinical importance of inhibitors. Haemophilia. 2014;20(4):76–79. doi: 10.1111/hae.12404.
  7. Collins P, Persy C. Advances in the understanding of acquired haemophilia A: implication for clinical practice. Br. J. Haematol. 2009;148(2):183–194. doi:10.1111/j.1365-2141.2009.07915.x.
  8. Collins P, Baudo F, Huth-Kihne A, Ingerslev J, Kessler CM, Castellano MEM, Shima M, St-Louis J, Lévesque H. Consensus, recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Research Notes. 2010;3:161 - 168. doi:10.1186/1756-0500-3-161.
  9. A United Kingdom Haemophilia Centre Doctors’ Organization (UKHCDO) guideline approved by the British Committee for Standards in Haematology Collins PW, Chalmers E, Hart D, Jennings I, Liesner R, Rangarajan S, Talks K, Williams M, Hay CRM. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br.J. Haematol. 2013;162(3):758–731. doi: 10.1111/bjh.12463.
  10. Mulliez SMN, Vantilborgh A, Devreese, KMJ. Acquired hemophilia: a case report and review of the literature. Int. Jnl. Lab. Hem. 2014; 36 (3):398–407. doi:10.1111/ijlh.12210.
  11. Sborov DW, Rodgers GM. How I manage patients with acquired haemophilia A. Br. J. Haematol. 2013;161(2):157–165. doi:10.1111/bjh.12228.
  12. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M and British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br. J. Haematol. 2012;157(1):47–58. doi:10.1111/j.1365-2141.2012.09037.x.
  13. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, Ludlam CA, Mahlangu JN, Mulder K, Poon MC, Street A, Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia (2nd). Haemophilia. 2013;19(1):e1-47. doi: 10.1111/j.1365-2516.2012.02909.x.
  14. Kottke-Marchant K. Algorithmic Approaches to Hemostasis Testing. Semin. Thromb. Hemost. 2014;40(02):195-204. doi: 10.1055/s-0033-1364187.
  15. Сollins P, Chalmers E, Hart D, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th). Br. J. Haematol. 2013;160(2):153 - 170. doi:10.1111/bjh.12091.
  16. Krasivska V, Stasyshyn О. Rol skryningovogo testu u diagnostyci ingibitoriv do faktora VIII(IX) u hvoryh na gemophiliu [The role of screening test in the diagnosis of inhibitors to factor VIII (IX) in hemophilia patients]. Circulation and haemostasis. 2015;1/2:49-53.
  17. Favaloro EJ, Verbruggen B, Miller CH. Laboratory testing for factor inhibitors. Haemophilia. 2014;20(4):94–98. doi: 10.1111/hae.12408.
  18. Kasper C, Aledort L, Counts R, Edron J, Fratantoni J, Green D, Hampton J, Hilgartner M, Laserson J, Levine P, MacMillan, C, Pool J, Shapiro S, Shulman N, Eys J. Measurement of factor VIII inhibitors. Thromb.Diath. Hemorrhagica. 1975;34:869 - 872.
  19. Chantarangkul V, Biguzzi E, Asti D, Palmucci C, Tripodi A.Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant. J. T. H. 2013;110(1):46–52. doi:10.1160/TH12-11-0850.
  20. Moore GW. Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants. Semin. Thromb. Hemost. 2014;40(2):163–171. doi:10.1055/s-0033-1364185.
  21. Laffan MA, Lester W, O’Donnell JS Will A, Tait RC, Goodeve A, Millar CM, Keeling DM. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br. J. Haematol.2014;167(4):453–465. doi:10.1111/bjh.13064.
  22. Roberts JC, Flood VH. Risky business: the interpretation, use, and abuse of Laboratory diagnosis of von Willebrand disease. Int. Jnl. Lab. Hem. 2015; 37(S1):11–17. doi: 10.1111/ijlh.12345.
  23. Miller CH, Rice AS, Boylan B, Shapiro AD, Lentz SR, Wicklund BM, Kelly FM, Soucie JM; Hemophilia Inhibitor Research Study Investigators. Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study. J. T. H. 2013;11(7):1300–1309. doi: 10.1111/jth.12259.

EXCHANGE OF BIOGENIC ELEMENTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CONCOMITANT HYPERTENSION

Аuthors: V. A. Kapustnik, O. V. Istomina

Pages: 396–400

Abstract

         

Introduction. In the structure of therapeutic pathologies and occupational lung disease, chronic obstructive pulmonary disease (COPD) takes one of the leading places. Quite frequently an association was found between COPD and hypertension. COPD combined with hypertension has its own characteristics, due to the close functional relationship between hemodynamic and respiratory systems. Works of many authors devoted to study of biogenic elements indicate the important role of providing a balanced body tissue by iron, magnesium, phosphorus and calcium for normal course of numerous metabolic reactions and physiological functions. The study of metabolic disorders of biogenic elements mechanisms remains relevant for understanding of the causal relationships of this comorbid pathology.

Purpose. The aim of the study was to identify the most informative indicators for the diagnosis of chronic obstructive pulmonary disease (COPD) in combination with hypertension by studying the content of biogenic elements in the blood plasma.

Materials and Methods. According to the design of the study we examined the activity of biogenic elements in patients with COPD combined with hypertension (main group), in which 55 patients were included; in patients with isolated COPD (control group), which consisted of 45 patients and a group of healthy subjects (control group), which included 45 patients. The average age of all three groups of patients was 55.4 ± 10.7 years. The biogenic elements content in the blood serum was investigated biochemically. Statistical analysis of the results of experimental studies was carried out using a computer application package for the processing of statistical information Statistica 6.1 (StatSoft, Inc., the USA). As a critical significance level there was accepted p < 0.05 when testing the statistical hypotheses.

Discussion. Patients with chronic obstructive pulmonary disease, especially chronic obstructive pulmonary disease in combination with hypertension demonstrated a violation of the exchange of biogenic elements. The nature and extent of violations of the exchange of nutrients can be considered as a diagnostic criterion for determining the state of the energy and mineral metabolism in patients with this pathology, and allows you to predict the severity of chronic obstructive pulmonary disease with concomitant hypertension. Informative and diagnostically meaningful parameters for the diagnosis and determine the severity of chronic obstructive pulmonary disease in combination with hypertension may be high levels activity of iron and calcium.

Keywords: chronic obstructive pulmonary disease, hypertension, biogenic elements.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. World health organization. The top 10 causes of death 2014. Retrieved from: http://www.who.int/mediacentre/factsheets/fs355/en/.
  2. Jakovleva LV, Vasil'eva AA, Kuznecov IJe. [COPD: epidemiological aspects]. Farmakoekonomіka v Ukraїnі: stan ta perspektivi rozvitku: materіali VІ naukovo.- praktichnoi. Konferencіi. [Pharmacoeconomics in Ukraine: state and prospects of development of materials IV naukovo.- practical. conference.] H.: Vid-vo NFaU Publ, 2013, pp. 9–21.
  3. Drozdova IV, Macuga ON, Hramcova VV. [Distribution model lung function and personality particularly those with COPD]. Suchasni medichni tehnologіi. 2014;1:90–96.
  4. Mazitova NN. [Occupational factors and chronic obstructive pulmonary disease: a meta-analysis]. Fundamental'nye issledovanija. 2011; 9:588–592
  5. Frits ME, Rochester LC. [Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?]. Eur Respir Rev. 2014;131:131–141.
  6. Luk'janchikov VS. [Calcium: Physiology. Ontogenetic and clinical aspects]. Novye issledovanija. 2012;2(31):5–13.
  7. Iordanskaja FA, Cepkova NK. [Phosphorus of blood: diagnostic and prognostic value in monitoring the functional state of elite athletes]. Vestnik sportivnoj nauki. 2011;4:30–33.

LIVER RESECTION AND DIAPHRAGM STRIPPING IN RECURRENT OVARIAN TUMORS

Аuthors: V. V. Boyko,  K. V. Kharchenko,  S. O. Savvi

Pages: 401–409

Abstract

         

Diaphragm and liver are common sites of primary and recurrent ovarian tumor lesions. Such cases represent tumor’s biological features. Optimal cytoreduction is the aim both at the primary and subsequent surgery due to its survival improvement effect.

Purpose: to investigate safety and effectiveness of surgical treatment of recurrent ovarian tumors localized on the liver and diaphragm.

Materials and methods. The data of eleven patients treated in the State Establishment « V. T. Zaitsev Institute of General and Emergency Surgery of Academy of Medical Sciences of Ukraine» during January 2001 – December 2010 was included in the current study. Optimal cyto­reduction was achieved during primary surgery in all cases. Surgical treatment for recurrent ovarian tumor included stripping of the diaphragm and any liver surgery.

Results. Diagnosis and surgical treatment of synchronous recurrent ovarian tumors in the liver and diaphragm were performed at a mean age (61.13 ± 5.12) years (48–70 years). The median duration of disease-free period was 23 months (6–124 months). Median serum CA-125 level was 151 U/ml (43–1120 U/ml). Preoperatively diaphragm lesion was diagnosed in 7 (64 %) cases. In 4 (36 %) cases tumor was an intraoperative finding. There were no cases of isolated lesions of the left hemidiaphragm. Recurrent tumors in the liver were localized in one lobe in 9 (82 %) cases, in two – 2 (18 %). Number of foci in the liver: 1–6 (55 %) 2–4 (36 %) 3–1 (9 %). Diameter < 5 cm was found in 8 (73 %) cases, ≥ 5 cm – 3 (27 %). The median diameter was 3.8 cm (1–6.3 cm). Surgical interventions performed on liver:   wedge resection (n = 2; 18 %), segmentectomy (n = 6; 55 %) bisegmentectomy (n = 2; 18 %), lobectomy (n = 1; 9 %). The number of diaphragm tumor lesions (including bilateral) was 1 (n = 5; 46 %), 2 (n = 3; 27 %), 3 (n = 1; 9 %), 4 (n = 1; 9 % ), 5 (n = 1; 9 %). The median diameter of the largest recurrent tumor on the diaphragm was 2.8 cm (1–4 cm). Postoperative complications occurred in 2 (18 %) patients. Complications did not affect the duration of hospitalization and dates for adjuvant therapy. All patients received chemotherapy after surgery. The level of postoperative mortality was 0 %. The median overall survival after secondary cytoreduction was 24 months. (9–89 months), 5‑year survival rate – 27 %. CA-125 serum concentration, size, number and location of secondary tumors of the liver and the diaphragm did not correlate with survival rates.

Discussion. Diagnosis of synchronous secondary lesions of diaphragm and liver should be improved as well as technical aspects of the combined surgical interventions. It is important to provide further investigations to individualize indications for their implementation.

Keywords: thyroid cancer, biomineralization, immunohistochemistry, markers, apoptosis, osteopontin.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Tan DS, Argarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006; 7:925–934.
  2. Sehouli J, Senyuva F, Fotopoulou C et al. Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J. Surg. Oncol. 2009; 99:424–427.
  3. Cliby W, Dowdy S, Feitoza SS et al. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol. Oncol. 2004; 94:655–660.
  4. Einekel J, Ott R, Handzel R et al. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube or peritoneal cancer. Int. J. Gynecol. Cancer. 2009; 19:1288–1297.
  5. Eisenhauer EL, Chi DS. Liver mobilization and diaphragm peritonectomy/resection. Gynecol. Oncol. 2007; 104:25–28.
  6. Zivanovic O, Eisenhauer EL, Zhu K et al. The impact of bulky upper abdominal disease cephalad of the greater omentum and surgical outcome for stage IIIC epithelial ovarian, fallopian tube and primary peritoneal cancer. Gynecol. Oncol. 2008; 108:287–292.
  7. Rose PG, Piver MS, Tsukada Y et al. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer. 1989; 64:1508–1513.
  8. Papadia A, Morotti M. Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature. Arch. Gynecol. Obstet. 2013; 287:733–741.
  9. Mattar RE, Al-Alem F, Simoneau E et al. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J. Gastroenterol. 2016; Jan 14;22(2):567–81.
  10. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with biological aggressiveness and survival? Gynecol. Oncol. 2001; 82:435–441.
  11. Kapnick SJ, Griffiths CT, Finkler NJ. Occult pleural involvement in stage III ovarian carcinoma: role of diaphragm resection. Gynecol. Oncol. 1990: Nov;39(2):135–8.
  12. Eisenhauer EL, D'Angelica MI, Abu-Rustum NR et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol. Oncol. 2006; Dec;103(3):871–7.
  13. Bogani G, Ditto A, Martinelli F et al. Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and Meta-analysis. Int. J. Gynecol. Cancer. 2016; Feb;26(2):371–80.
  14. Devolder K, Amant P, Neven T et al. Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int. J. Gynaecol. Cancer. 2008; 18:363–368.
  15. Dowdy SC, Loewen RT, Aletti G et al. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian cancer. Gynecol. Oncol. 2008; 109:303–307.
  16. Terauchi F, Okamoto A, Wada Y et al. Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer. Oncol. Lett. 2010; 1:861–864.
  17. Chereau E, Ballester M, Selle F et al. Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer. BJOG. 2009; 116:1062–1068.
  18. Aletti GD, Dowdy SC, Podratz KC et al. Surgical treatment of diaphragmatic disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol. Oncol. 2006; 100:283–287.
  19. Eisenhauer EL, Abu-Rustum NR, Sonoda Y et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol. Oncol. 2006; Dec;103(3):1083–90.
  20. Pekmezci S, Saribeyoglu K, Aytac E et al. Surgery for isolated liver metastasis of ovarian cancer. Asian J. Surg. 2010; 30(2):83–88.
  21. Meredith MA, Cliby WA, Keeney GL et al. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol. Oncol. 2003; 89:16–21.
  22. Kolev V, Pereira EB, Schwartz M et al. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int. J. Gynecol. Cancer. 2014; 24(1):70–74.
  23. Niu G, Shen C, Cui W et al. Hepatic resection is safe for metachronous hepatic metastases from ovarian cancer. Cancer Biol. Med. 2012; 9:182–187.
  24. Roh HJ, Kim DY, Joo WD et al. Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch. Gynecol. Obstet. 2011; 284(5):1223–1229.
  25. Abood G, Bowen M, Potkul R et al. Hepatic resection for recurrent metastatic ovarian cancer. Am. J. Surg. 2008; 195:370–373.

CLINICAL AND NEUROPHYSIOLOGICAL COMPARISON OF COGNITIVE FUNCTIONS EVALUATION IN PATIENTS WITH A MILD CEREBRO-CRANIAL INJURY

Аuthors: O. S. Solonovych, L. L. Chebotariova, N. V. Kadzhaya, A. I. Trеtiakova

Pages: 410–418

Abstract

         

Objective: Determine the criteria of cognitive impairment objectivization in patients with a mild cranio-cerebral injury.

Materials and Methods: 70 patients aged from 18 to 45 who suffered from a mild brain concussion or a brain contusion were examined(GCS 13-15). 40 healthy persons of the same age were examined in the control group. The following methods were used for their examination: a clinical and neurological estimation, neuropsychological testing with the use of various scales, ultrasonography of brain vessels, digital electroencephalography, recording of cognitive auditory evoked potentials.

Results: Complaint frequency in the interim and long-term periods in patients who suffered from a mild cerebro-cranial injury was as follows: complaints of headache – 21.43 %; complaints of memory impairment – 30 %. According to the neuropsychological testing with the help of Montreal Cognitive Assessment (MoCA) and Hospital Anxiety and Depression Scale (HADS), evidence disorder were found in 21.31 % of the patients, memory impairment – in 34.42 %, anxiety and depression – in 26.31 %. Other neuropsychological methods, such as the computerized Lüscher color test, Stroop test, Bourdon test, were less sensitive. According to the cognitive auditory evoked potentials, a significant increase of P3 latency peak was recorded in 42.1 % of the patients; a decrease of evoked potentials amplitude – in 44.72 %. According to the electroencephalography, a tendency for disorganization of the main cortical rhythms in the form of diffuse slowing or acceleration, alpha-rhythm disorganization in frequency and amplitude.

Conclusion: In order to objectivize cognitive impairment in patients with mild cerebro-cranial injuries in the interim and long-term periods for screening purposes, it is appropriate to carry out a neuropsychological testing with the help of MoCA and HADS scales, neurophysiological examination: digital electroencephalography and recording of cognitive auditory evoked potentials.

Keywords: mild cerebro-cranial injury, diagnosis of cognitive impairment, cognitive evoked potentials.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Numminen HJ. The incidence of traumatic brain injury in an adult population—how to classify mild cases. Eur J Neurol. 2011;18:460–464.
  2. Andersson EH, Bjorklund R, Emanuelson I, Stalhammar D. Epidemiology of traumatic brain injury: a population based study in western Sweden. Acta Neurol Scand. 2003;107:256–259.
  3. Cassidy JD, Carroll LJ, Peloso PM, et al. Incidence, risk factors and prevention of mild traumatic brain injury: Results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J Rehabil Med. 2004; (43 Suppl):28–60.
  4. Collins M, Lovell MR, Iverson GL, Ide T, Maroon J. Examining concussion rates and return to play in high school football players wearing newer helmet technology: A three-year prospective cohort study. Neurosurgery. 2006;58:275–286.
  5. Rimel R, Giordani B, Barth J, et al. Disability caused by minor head injury. Neurosurgery. 1981;9:221–223.
  6. Schretlen D, Shapiro A. A quantitative review of the effects of traumatic brain injury on cognitive functioning. Int Rev Psychiatry. 2003;15:341–349.
  7. Otis JD, McGlinchey R, Vasterling JJ, Kerns RD. Complicating Factors Associated with Mild Traumatic Brain Injury: Impact on Pain and Posttraumatic Stress Disorder Treatment. J Clin Psychol Med Settings. 2011; 18:145–154.
  8. Monrealskaya shkala otsenki kognitivnykh funktsij [The Montreal Cognitive Assessment]. Neuronews. Retrieved from: http://neuronews.ru/index.php/spravochnye-materialy/shkaly-i-testy/item/573-monrealskaya-shkala-otsenki-kognitivnykh-funktsij
  9. Gospital'naya Shkala Trevogi i Depressii [Hospital Anxiety and Depression Scale]. Retrieved from: http://paracels55.ru/_ld/0/2_HADS_SR_Scale.pdf
  10. Recommendations and standards of EEG. American Society of Clinical Neurophysiology ASCN. The International Federation of Clinical Neurophysiology IFCN. Retrieved from: http://eeg-online.ru/standards/home.htm
  11. Gnezditskiy VV, Korepina OS. Atlas po vyzvannim potencialam mozga. [Atlas of evoked potentials of the brain]. Ivanovo Publ, 2011, pp. 286–309.
  12. Semchishin MG, Shevaga VM, Zadorozhna BV. [Brain bloodstream in mild and middle traumatic brain injury in acute and intermediate period according to Doppler ultrasound data]. Bukovinskiy medichniy visnuk. 2015;1:142–145.
  13. Muravskiy AV, Globa MV, Mihal GV. [Features cerebral hemodynamics in boxers with repeated brain injuries]. Ukr. Nerolog. J. 2016;1:62–72.
  14. Len TK, Neary JP. Cerebrovascular pathophysiology following mild traumatic brain injury. Clin Physiol Funct Imaging. 2011;31:85–93.
  15. Jünger EC, Newell DW, Grant GA, Avellino AM, Ghatan S, Douville CM, Lam AM, Aaslid R, Winn HR. Cerebral autoregulation following minor head injury. J Neurosurg. 1997; 86(3):425–32.
  16. Litovchenko TA, Lebedynets VV, Iakubenko IuV, Novikova AA. The dynamics of hemodynamics indexs in patients with cosequences of mild traumatic brain injury. Ukrayinsʹkyy visnyk psykhonevrolohiyi. 2014; 22,4(81):37–40.
  17. Da Costa L, van Niftrik CB, Crane D, Fierstra J, Bethune A. Temporal Profile of cerebrovascular reactivity impairment, gray Matter Volumes, and Persistent symptoms after Mild Traumatic head injury. Frontiers in Neurology. 2016;7:70.
  18. Bouzat P, Francony G, Declety P, Genty C, Kaddour A, Bessou P, Brun J, Jacquot C, Chabardes S, Bosson JL, Payen JF. Transcranial Doppler to screen on admission patients with mild to moderate traumatic brain injury. Neurosurgery. 2011;68(6):1603–9.
  19. Tan CO, Meehan WP, Iverson GL, Taylor JA. Cerebrovascular regulation, exercise, and mild traumatic brain injury. Neurology. 2014;83:1665–1672.
  20. Grygorova IA, Kufterina NS. [Neurophysiological analysis of young people who have suffered mild traumatic brain injury]. Int. Neurol. J. 2011;7:43–46.
  21. Muravskiy AV, Chebotareva LL, Solonovych OS. [The study of cognitive evoked potentials (P300) in boxers with repeated mild brain injuries]. Ukr. Neurosurg. J. 2015; 3:63–69.
  22. Thatcher RW. Electroencephalography and mild traumatic brain injury. Foundations of Sport-Related Brain Injuries (Eds by Semyon M. Slobounov and Wayne J. Sebastianelli). Springer, 2006. 482 p.
  23. Trudeau DL, Anderson J, Hansen LM, Shagalov DN, Schmoller J, Nugent S, Barton S. Findings of mild traumatic brain injury in combat veterans with PTSD and a history of blast concussion. Journal of Neuropsychiatry and Clinical Neuroscience. 1998;10(3): 308–313.
  24. Thornton K. Exploratory investigation into mild brain injury and discriminant analysis with high frequency bands (32-64 Hz). Brain Injury. 1999;13(7):477–488.
  25. Thatcher RW, Biver CL, Gomez-Molina JF, North D, Curtin R, Walke RW, Salazar A. Estimation of the EEG Power Spectrum by MRI T2 Relaxation Time in Traumatic Brain Injury. Clinical Neurophysiology. 2001;112:1729–1745.
  26. Thatcher RW, Moore N, John ER, Duffy F, Hughes JR, Krieger M. QEEG and traumatic brain injury: Rebuttal of the American Academy of Neurology 1997 Report by the EEG and Clinical Neuroscience Society. Clinical Electroencephalograph. 1999;30(3): 94–98.
  27. Thatcher RW, Biver C, North D. Quantitative EEG and the Frye and Daubert Standards of Admissibility. Clinical Electroencephalography. 2003;34(2):39–53.
  28. Amyot F, Arciniegas DB, Brazaitis MP, Curley KC, Diaz-Arrastia R, Gandjbakhche A, Herscovitch P, Hinds SR, Manley GT, Pacifico A, Razumovsky A, Riley J, Salzer W, Shih R, Smirniotopoulos JG, Stocker D. A Review of the Effectiveness of Neuroimaging Modalities for the Detection of Traumatic Brain Injury. J Neurotrauma. 2015;15;32 (22):1693–721.
  29. Solbakk AK, Reinvang I, Svebak S, Nielsen CS, Sundet K. Attention to affective pictures in closed head injury: event-related brain potentials and cardiac responses. J Clin Exp Neuropsychol. 2005;27(2):205–23.

ANXIOUS AND EMOTIONAL ASPECT OF TENSION-TYPE HEADACHE IN ADOLESCENTS

Аuthors: K. A. Stepanchenko

Pages: 419–425

Abstract

         

Introduction. Despite the fact that tension-type headache in adolescents is considered an indicator of psycho-vegetative disorders, emotional and affective disorders in this cephalgia, as well as their role in the formation of tension-type headaches in adolescence are not well understood. The role of the school anxiety remains poorly known in occurrence of tension-type headaches in adolescents, despite the fact that many of them complain of a headache in the afternoon, after school.

Purpose. The aim of our study was to investigate the role of reactive, personal and school anxiety in the occurrence of tension-type headaches in adolescents.

Materials and methods. A total of 320 adolescents with tension-type headache have been under study. Research of the level of reactive and personal anxiety by Spielberg`s scale (Yu. L. Hanin modification (1978)), the level of school anxiety (Phillips`s scale) was performed.

Results. The number of adolescents with tension-type headache, with a high anxiety level was 306 persons (95.6 %). 61.9 % of patients had moderate reactive anxiety (р < 0.05), 28.1 % – high reactive anxiety (> 46 points), 66.9 % – high personal anxiety. The average level of reactive anxiety in adolescents with TTH was 40.9 ± 9.1 points; the average level of personal anxiety – 44.6 ± 9.5 points. In healthy teens average level of reactive anxiety was 28.6 ± 5.3, personal anxiety index was 32.3 ± 6.7. Thus, the anxiety level in the control group was significantly lower than in patients with tension-type headache (p < 0.05).

Adolescents with tension-type headache, compared with the control group had significantly increased the frustration of the need to achieve success, as well as the problems and fears in their relations with teachers. It should be noted that adolescents with episodic tension-type headache had increased and high indexes on the scale of examination, fear not match the expectations of others and general anxiety in school. Adolescents with chronic tension-type headache had increased level and adolescents with infrequent episodic tension-type headache – a high level of experience of social stress associated with the complexities of social interactions, especially – with their peers.

Conclusion. It was found that adolescents with tension-type headache have an increased level of reactive, personal and school anxiety, which is most pronounced in adolescents with episodic forms of tension-type headaches. With increasing frequency of episodes of tension-type headache there is increasing frequency of a low resistance to physiological stress.

Keywords: tension-type headache, adolescents, reactive anxiety, personal anxiety, school anxiety.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Blaauw BA, Dyb G, Hagen K, Holmen TL, Linde M, Wentzel-Larsen T, Zwart JA. The relationship of anxiety, depression and behavioral problems with recurrent headache in late adolescence – a Young-HUNT follow-up study. J Headache Pain. 2015. 16;16:10.
  2. Rocha-Filho PA, Santos PV. Headaches, quality of life, and academic performance in schoolchildren and adolescents. Headache. 2014;54(7):1194–202.
  3. Machnes-Maayan D, Elazar M, Apter A, Zeharia A, Krispin O, Eidlitz-Markus T. Screening for psychiatric comorbidity in children with recurrent headache or recurrent abdominal pain. Pediatr Neurol. 2014;50(1):49–56.
  4. Margari F, Lucarelli E, Craig F, Petruzzelli MG, Lecce PA, Margari L. Psychopathology in children and adolescents with primary headaches: categorical and dimensional approaches. Cephalalgia. 2013;33(16):1311–8
  5. Balottin U, Fusar Poli P, Termine C, Molteni S, Galli F. Psychopathological symptoms in child and adolescent migraine and tension-type headache: a meta-analysis. Cephalalgia. 2013;33(2):112–22.
  6. Manevich TM, Yahno NN, Sokolova ED. [Chronic tension-type headaches in children and adolescents: a clinical and psychological assessment] Zhurnal nevrol. i psih. im. S. S. Korsakova. 2004;2:4–7
  7. Casucci G, Terlizzi R, Cevoli S. Headache in school age. Neurol Sci. 2014;35 Suppl 1:31–5.
  8. Matar AK, Kerem NC, Srugo I, Genizi J. Primary headache in children and adolescents – diagnosis and treatment. Harefuah. 2015;154(12):795–8, 803.
  9. Black AK, Fulwiler JC, Smitherman TA. The role of fear of pain in headache. Headache. 2015;55(5):669–79.
  10. Headache Classification Committee of International Headache Society: International Classification of Headache Disorders 3rd Edition (beta version). Cephalalgia. 2013; 33(9):659–664.

CHANGES OF INTEGRATED, INTEGRATIVE ENDOGENOUS INTOXICATION INDICATORS AND IMMUNOREACTIVITY IN TREATMENT OF PATIENTS WITH SALMONELLOSIS

Аuthors: O. M. Chemych, L. V. Moroz

Pages: 426–441

Abstract

         

Introduction. Salmonella is the most common intestinal infection. The disease is topical for Ukraine. The main clinical feature of salmonellosis is intoxication – a complex of symptoms caused by the integrated action of microorganisms and their toxins on the one hand, and the reaction of the human body on the other hand. Dehydration syndrome with the syndrome of endogenous intoxication in clinic of salmonellosis determine the severity of the disease and its prognosis.

Purpose. To establish the effect of the applied treatment regimens in patients with salmonellosis by studying integral, integrative indices of endogenous intoxication and indicators immunoreactivity in different periods of illness.

Materials and methods. 189 patients with salmonellosis were examined in clinical and laboratory conditions. Depending on the resulting treatment all surveyed were divided into four group: SI – receiving basic therapy, SIІ – receiving basic therapy without the antibacterial agent adding researched probiotic, SIII – basic therapy and investigating probiotic SIV – basic therapy and other probiotics.

Results. Hematologic changes were identified and the main clinical and epidemiologic features of salmonellosis were analysed in the acute phase of the disease. Changes of integrative endogenous intoxication indicators point to the disturbances in the immune system of patients – the prevalence of humoral and cellular immunity suppression. Endogenous intoxication and severe inflammatory response were developed as a result of destruction of their own cells, and by the action of bacterial endo- and exotoxins. Delayed reactions dominate over hypersensitivity of immediate type in the acute period, during intoxication. This leads to the launch of allergic mechanisms. Rapid integral, integrative indices normalization of endogenous intoxication and immunoreactivity were observed in convalescents SIII and SII group.

Conclusion. In patients the positive effect was observed when investigated combined probiotic was added to the treatment regimen. In groups SIII and SII quickly normalized integral, integrative indicators and immunoreactivity.

Keywords: salmonella, clinic, integrated indicators, integrative indicators, endogenous intoxication, treatment regimens, probiotics.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Еheita Sarrionandia MA, León SH, Baamonde CS. Invasive gastroenteritis, anything new? Enferm. Infecc. Microbiol. Clin. 2011; 3: 55–60.
  2. Khan MI, Soofi SB, Ochiai RL. Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan. J. Infect. Dev. Ctries. 2012; 6(10): 704–714.
  3. Barrow PA, Jones MA, Smith AL, Wigley P. The long view: Salmonella - the last forty years. Avian Pathol. 2012; 41(5): 413–420.
  4. Bubalo VO. [Cuchasniy stan zahvoryuvanosti na salmonelozi v Ukrayini] Ukrayinskiy medichniy almanah. 2013; 16(3): 26–28.
  5. Andreychin MA. Infektsiyni hvorobi v zagalniy praktitsi ta simeyniy meditsini [Infectious diseases in common practices and family medicine] Ternopil: TDMU Publ., 2007, 298–349.
  6. Ivahiv OL, Gritsko RYu, Kiselik IO. Kabinet infektsiynih zahvoryuvan: navchalniy posibnik [The Cabinet infectious diseases: Tutorial]. Ternopil: TDMU Publ., 2006, 84–98.
  7. Berezhnoy VV, Yankovskiy DS, Kramarev SA. [Narusheniya mikrobnoy ekologii cheloveka, ih prichiny, posledstviya i sposoby vosstanovleniya fiziologicheskoy normy]. Zdorove zhenshchiny. 2004; 2(18):170–178.
  8. Hermann C. Variability of hostpathogen interaction. Journal of endotoxin research. – 2007; 13: 199–218.
  9. Andreychin SM, Golomsha TO. [Suchasni uyavlennya pro metabolichnu endogennu intoksikatsiyu]. Infektsiyni hvorobi. 2012; 1(67): 84–88.
  10. Chemych MD, Andreychin MA, Zahlebaeva VV. [Integrativni pokazniki endogennoyi intoksikatsiyi organizmu ta gematologichni zmini pri shigelozi]. Infektsiyni hvorobi. 2009; 2: 42–47.
  11. Siplivyy VA, Kon EV, Evtushenko DV. [Ispolzovanie leykotsitarnyh indeksov dlya prognozirovaniya ishoda peritonita]. Klinichna hirurgiya. 2009; 9: 21–26.
  12. Golubovska OA. Infektsiyni hvorobi: pidruchnik [Infectious disease: textbook]. K.: VSV «Meditsina» Publ., 2012, 31–75.
  13. Odinets TM, Karimov IZ, Shmoylov DK. [Rol bakteriynoyi translokatsiyi v patologiyi]. Infektsiyni hvorobi. 2011; 4: 71–76.
  14. Ostrovska LY, Moshel TM, Ivanitskiy IO. [Analiz pokaznikiv gemogram u patsientiv iz zapalnimi i zapalno–distrofichnimi zminami tkanin parodonta]. Visnik problem biologiyi i meditsini. 2016; 1 (126): 360–363.
  15. Ostrovskiy VK. [Pokazateli krovi i leykotsitarnogo indeksa intoksikatsii v otsenke tyazhesti i opredelenii prognoza pri vospalitelnyh, gnoynyh i gnoyno-destruktivnyh zabolevaniyah]. Klin. lab. diagn. 2006; 6: 50–53.
  16. Speranskiy II, Samoylenko GE, Lobacheva MV. [Obshchiy analiz krovi – vse li ego vozmozhnosti ischerpany? Integralnye indeksy intoksikatsii kak kriterii otsenki tyazhesti techeniya endogennoy intoksikatsii, ee oslozhneniy i effektivnosti provodimogo lecheniya]. Zdorove Ukrainy. 2009; 6 (19): 51–57.
  17. Mustafina ZhG, Kramorenko YuS, Kobtseva VYu. [Integralnye gematologicheskie pokazateli v otsenke immunologicheskoy reaktivnosti organizma u bolnyh s oftalmopatologiey]. Klin. lab. diagnostika. 1999; 5: 47–49.
  18. Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl. Lek. Listy. 2001; 102(1): 5–14.
  19. Raznatovskaya EN. [Integralnye indeksy endogennoy intoksikatsii u bolnyh himiorezistentnym tuberkulezom legkih]. Aktualni pitannya 120 farmatsevtichnoyi i medichnoyi nauki ta praktiki. 2012; 2 (9): 119–120.
  20. Nichitaylo MYu, Kondratyuk OP, Snopok YuV. [Pankreonekroz. Profilaktika infikuvannya ta likuvannya infektsiynih uskladnen]. Ukr. zh. hirurgiyi. 2009; 4: 104–108.
  21. Ivashchuk SI. [Imunologichna reaktivnist organizmu hvorih na gostriy pankreatit zalezhno vid genezu ]. Bukovinskiy medichniy visnik. 2014; 18(4) (72): 38–42.

PECULIARITIES OF DIAGNOSIS AND COMPLEX TREATMENT OF FERTILE AGE WOMEN WITH BACKGROUND CERVICAL DISEASES

Аuthors: I. Makagonov

Pages: 442–446

Abstract

         

The article describes the main causes of background diseases of cervix of the uterus, highlights the issues of diagnosis and complex treatment of this pathology, based on a consistent set of examination: colposcopy, cytology, gіstology. The aim of this study was to investigate of the efficacy and safety of using the drug Colpotrophine compared with Methyluracilum after destructive treatment of cervical pathology based on the data of the scientific literature and own research and improve the algorithm for diagnosis of background cervical diseases.

The study involved 60 women of reproductive age who were diagnosed for background diseases of cervix of the uterus. The technique of postoperative preventive maintenance of complications, accelerations reparative processes and quality improvement epithelization is offered at use local destructive methods of treatment of the pathology of cervix of the uterus.

Results of the spent researches testify that the complex approach to the decision of a difficult scientific problem with additional use of Colpotrophine allows to raise efficiency of treatment and to lower frequency recediving.

Colpotrophine demonstrates regenerative properties and promotes complete epithelialization of the cervix. Studies have shown that the drug is well tolerated.

Results of the study can be recommended to include complex examination of patients with background diseases of cervix of the uterus transvaginal echography to diagnose ectopic glands deep cysts that are impossible to detect visually and by colposcopy.

Keywords: background diseases of cervix of the uterus, ultrasound diagnostic, treatment, regeneration, Colpotrophine.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Voloshina NN. Tservikalnyie intraepitelialnyie neoplazii (diagnostika, lechenie, profilaktika) [Cervical intraepithelial neoplasia (diagnosis, treatment, prevention)]. Zaporozhe Publ., 2007, 57–60.
  2. Prilepskay VN. Zabolevaniya sheyki matki, vlagalischa i vulvyi. Klinicheskie lektsii [Diseases cervix, vagina and vulva. Clinical Lectures]. 4-th. M.: MEDpress-inform Publ., 2005. 390 p.
  3. Chayka VK. Infektsii v akusherstve i ginekologii: Prakt. Rukovodstvo [Infection in obstetrics and gynecology]. Donetsk: OOO «Almateo» Publ., 2012. 640 p.
  4. Kasyanova NV, Kalinovska NE. [Experience in diagnosis and treatment of benign and precancerous lesions of the cervix in women of reproductive age]. Meditsina transportu Ukrayni. 2008;(1):39–43.
  5. Nakaz MOZ Ukrayini # 676 vId 31.12.2004 Pro zatverdzhennya klInIchnih protokolIv z akusherstva ta gInekologIchnoyi patologIyi. [On approval of clinical protocols for obstetrics and gynecological pathology].
  6. Kohanevich EV. Patologiya sheyki i tela matki: Rukovodstvo dlya vrachey. [Pathology of cervix and uterine body] . Nezhin: Gidromaks Publ., 2009. 352 p.
  7. Rusakevich PS, Litvinova TM. Zabolevaniya sheyki matki u beremennyih: diagnostika. Lechenie, monitoring, profilaktika. [Cervical disease in pregnancy: diagnosis. Treatment, monitoring, prevention]. Minsk: BelMAPO Publ., 2002; 140 p.
  8. Dolgoshapko OM, Pavlushenko SD, Babenko OM. [Risk factors for recurrence of benign cervical diseases]. Tavricheskiy mediko – biologicheskiy vestnik. 2012 ; 15 (2): 93–95.
  9. Tatarchuk TF, Tutchenko TN. [Cervical pathology]. Reproduktivnaya endokrinologiya. 2013; (1) :39–47.
  10. Sadler L, Saftlas A, Wang W et al. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA. 2004; 291:2100–2106.
  11. Schafer ZT, Brugge JS. IL-6 involvement in epithelial cancers. J Clin Invest. 2007; 117 (12): 3660–3663.

EARLY AND DELAYED REACTION OF HIF-1α PROTEIN FOR BILATERAL CAROTID ISCHEMIA-REPERFUSION IN DIFFERENT LOBES OF RAT NEOCORTEX WITH EXPERIMENTAL DIABETES MELLITUS

Аuthors: T. I. Kmet’, O. G. Kmet’

Pages: 447–452

Abstract

         

Introduction. During the last decade a progressing growth of patients with diabetes mellitus has been marked. Ischemic stroke occupies one of the leading places by the occurrence of complications and mortality of patients with diabetes. The hypoxic-transcription factor HIF-1α is an important promoter to form the mechanisms of resistance to oxygen-substrate deficiency in the cerebral cortex.

Purpose. The objective of the study is to find the peculiarities of HIF‑1α protein reaction to incomplete global cerebral ischemia with reperfusion of various durations in separate lobes of the cerebral neocortex in male rats with experimental diabetes mellitus and to make their comparative analysis.

Materials and Methods. Streptozotocin was injected to two-month male rats to simulate diabetes mellitus. In a part of the animals general carotid arteries were clipped bilaterally at the age of 5 month for 20 minutes, after that blood flow was renewed to achieve reperfusion. To study early results of ischemia-reperfusion a part of the animals were deactivated from the experiment 1 hour after reperfusion period was over, for the delayed results – on the 12th day. According to the coordinates of the stereotaxic atlas the cortex of the frontal, parietal and temporal cerebral lobes was isolated. With the aim to identify cells expressing HIF-1α protein indirect immunofluorescent method was used.

Discussion. The results of the experimental study were indicative of the fact that diabetes mellitus modifies the reaction of antihypoxic HIF‑1α protein in early ischemic-reperfusion period in the cortex of the frontal and parietal lobes, and on the 12th day of the experiment–in all the lobes of the cortex examined.

Keywords: diabetes mellitus, carotid ischemia-reperfusion, HIF‑1αprotein.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. American Diabetes Association. Diabetes Care. 2015;38(1):1–594.
  2. Turenkov IN, Voronkov AV, Slietsans AA. [Role of endothelial dysfunction in the development of vascular complications of diabetes]. Pathological physiology and experimental therapy. 2013;2:80–84.
  3. Mendez JD. Trends in advanced glycation end products research in diabetes mellitus and its complications. Mol. Cell. Biochem. 2010;341(1-2):33–41.
  4. Wang L, Deng W, Yuan Q, Yang H. [Exercise preconditioning reduces ischemia reperfusion-induced focal cerebral infarct volume through up-regulating the expression of HIF-1α]. Pak J Pharm Sci. 2015;28(2):791–798.
  5. Xiyong Fan, Cobi J. Heijnen, Michael A. van der Kooij, Floris Groenendaala, Frank van Bel. The role and regulation of hypoxia-inducible factor-1α expression in brain development and neonatal hypoxic–ischemic brain injury. Brain research reviews. 2009;62:99–108.
  6. Tkachuk SS, Lenkov AM. [Expression of HIF-1α, р53 and Bcl-2 proteins in the brain under the conditions of bilateral carotid ischemia-reperfusion in experimental diabetes mellitus in male rats]. Clin and Exp Pathol. 2010;9(2):111-113.
  7. Boychuk TM, Kmet TI. [Peculiarities of the influence of streptozotocinineinduced diabetis and incomplete ischemia-reperfusion of the brain on apoptosis of various neocortical lobes of rats]. Fiziol Zh. 2016;62(2):72-78.
  8. Bassirat M, Khalil Z.  Short- and long-term modulation of microvascular responses in streptozotocin-induced diabetic rats by glycosylated products. J Diab Compl. 2008;22(6):371–376.
  9. Skibo GG. [The use of various experimental models to study cellular mechanisms of cerebral ischemic lesions]. Patologija. 2004;1(1):22–30.
  10. Kоnig JF, Klippel PA. The rat brain. A stereotaxis atlas of forebrain and lower part of the brain stem. Baltimora: The Williams and Wilkins Company, 1963. 162 p.
  11. Kolesnik YM, Abramov AV. Image analysis system for quantitative immunofluorescence measurement. Microscopy and Analysis. 2002;5:12–16.
  12. Shlyakhto EV, Barantsevitch ER, Shcherbak NS, Galagudza MM. [Molecular mechanisms of evelopment of cerebral tolerance to ischemia. Part 1]. Annals of the Russian Academy of Medical Sciences. 2012;6:42–50.

GENDER DIFFERENCES IN THE ASSOCIATION OF VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 GENE PROMOTER POLYMORPHISM WITH ISCHEMIC ATHEROTHROMBOTIC STROKE

Аuthors: Ye. I. Dubovyk,  Ye. A. Harbuzova,  A. V. Ataman

Pages: 453–460

Abstract

         

Introduction. Vitamin K epoxide reductase complex subunit 1 (VKORC1) is integral 163-amino acid long transmembrane protein (18 kDa) which is widely expressed in many organs and tissues of the human and animal organisms and it is necessary for activation of vitamin K-dependent coagulation factors (II, VII, IX, X), anticoagulation factors (Protein C, S, Z) and proteins with anti-calcification properties (Matrix Gla-protein, Gla-rich protein) in the vitamin K cycle. It can be assumed that VKORC1 dysfunction might cause activity reduction of vitamin K-dependent proteins, and thus might lead to thrombosis and vascular calcification. Considering the above mentioned the aim of present work was to perform a case-control study on representatives of both genders of the north-eastern region of Ukraine in order to assess the possible association between VKORC1 gene promoter G-1639A polymorphism with ischemic atherothrombotic stroke (IAS).

Materials and methods. The study group included 170 unrelated Ukrainian patients with a mean age of 64.7 ± 0.73 years who had IAS. The control group consisted of 124 clinically healthy individuals with the absence of cardio-vascular pathologies. VKORC1 promoter G-1639A (rs9923231) polymorphism genotyping was performed using PCR-RFLP (polymerase chain reaction with following restriction fragment length polymorphism analysis) method. Most statistical analyses were performed using Statistical Package for Social Science software (SPSS, version 17.0, Chicago, IL, USA). All statistical tests were two-sided, P < 0.05 was considered significant.

Results. It was shown that ratio of main homozygotes, heterozygotes and minor homozygotes in stroke patients was 39.4 %, 48.8 %, 11.8 % (in control – 34.7 %, 53.2 %, 12.1 %, P = 0.027). Genotypic association between G-1639A polymorphism and IAS was revealed in women after adjustment for covariates of age, BMI, smoking status and arterial hypertension under dominant (Padj = 0.038, ORadj = 2.848, 95 % CI = 1.058–7.665 for G/A and A/A genotypes) and additive (Padj = 0.049, ORadj = 2.888, 95 % CI = 1.006–8.293 for G/A genotype) model. In men significant difference was present only in the crude additive model (Pobs = 0.049, ORobs = 2.240, 95 % CI = 1.002–5.007 for A/A genotype), but was lost after adjustment (Padj = 0.077).

Conclusion. Obtained results suggested that -1639A allele can be a possible genetic risk factor for ischemic stroke in women in Ukrainian population.

Keywords: VKORC1, gene polymorphism, ischemic stroke.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation. 2011; 123(4):18–209.
  2. Rothwell PM. Atherothrombosis and ischaemic stroke. BMJ. 2007; 334(7590):379–380.
  3. Haeusler KG, Grittner U, Fiebach JB, Endres M et al. HEart and BRain interfaces in Acute ischemic Stroke (HEBRAS) – rationale and design of a prospective oberservational cohort study. BMC Neurol. 2015;15:213.
  4. Jickling GC, Sharp FR. Blood biomarkers of ischemic stroke. Neurotherapeutics. 2011;8(3):349–360.
  5. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey,
  6. Lazaros L, Markoula S, Kyritsis A, Georgiou I. Paraoxonase gene polymorphisms and stroke severity. Eur J Neurol. 2010;17(5):757–759.
  7. Keavney B1, McKenzie C, Parish S, Palmer A. Large-scale test of hypothesised associations between the angiotensin-convertingenzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet. 2000;355(9202):434–442.
  8. El Asmar MS, Naoum JJ, Arbid EJ. Vitamin K Dependent Proteins and the Role of Vitamin K2 in the Modulation of Vascular Calcification: A Review. Oman Med J. 2014;29(3): 172–177.
  9. O'Young J, Liao Y, Xiao Y, Jalkanen J et al. Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J Am Chem Soc. 2011;133(45):18406–18412.
  10. Adams HP Jr1, Bendixen BH, Kappelle LJ, Biller J et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.
  11. Wang D, Chen H, Momary KM et al. Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. Blood. 2008;112(4):1013–1021.
  12. Porojan M, Dumitraşcu DL. Genetic polymorphism of VKORC1 and KLOTHO genes associated with atherosclerosis. Clujul. Medical. 2012;85(4):533–536.
  13. Wang Y, Zhang W, Zhang Y, Yang Y et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation. 2006;113(12):1615–1621.
  14. Shyu HY, Fong CS, Fu YP, Shieh JC et al. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke. Clin Chim Acta. 2010;411(11-12):840–845.
  15. Hindorff LA, Heckbert SR, Smith N, Marciante KD, Psaty BM. Common VKORC1 variants are not associated with arterial or venous thrombosis. J Thromb Haemost. 2007;5(10):2025–2027.
  16. Ragia G, Marousi S, Ellul J et al. Association of Functional VKORC1 Promoter Polymorphism with Occurrence and Clinical Aspects of Ischemic Stroke in a Greek Population. Disease Markers 2013;35(6):641–646.
  17. Lemmens R, Abboud S, Vanhees L et al. Lack of association between variants in the VKORC1 gene and cerebrovascular or coronary heart disease. Journal of Thrombosis and Haemostasis. 2008;6:2220–2223.
  18. Arnold M-L, Lichy C, Werner I et al. Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population. Thrombosis and Haemostasis. 2008;100(4):614–617.
  19. Krueger T, Westenfeld R, Schurgers L, Brandenburg V. Coagulation meets calcification: the vitamin K system. Int J Artif Organs. 2009;32(2):67–74.
  20. Wallin R, Schurgers L, Wajih N. Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb. Res. 2008;122:411–417.
  21. Abedin M, Tintut Y, Demer L. Vascular calcification. Mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 2004;24:1161–1170.